Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study

ConclusionsNebivolol was associated with significantly lower risk of hospitalization due to composite cardiovascular events than atenolol or metoprolol in this large retrospective cohort study of monotherapy with three different β1-selective blockers in hypertensive patients.FundingAllergan plc, Madison, NJ, USA.
Source: Cardiology and Therapy - Category: Cardiology Source Type: research